ACCESS THE ON-DEMAND RECORDING HERE

Price: $40 USD Members / $120 USD Non-Members.

The workshop was held on September 11-12, 2024. Thank you to all who attended! Please look out for the 201 Biobanking workshop details coming soon.

Part 1 - ISBER Tool highlight: Essentials of Biobanking course  

The Essentials of Biobanking Course is a tool available on the ISBER website. It was developed by the Canadian Tissue Repository Network (CTRNet) and modified with country-specific content with input from international biobanking experts. The Essentials of Biobanking Course is based on ISBER Best Practices and is regularly updated and the purpose is to give you a general overview of the key issues in establishing, maintaining, and accessing a biobank.
The course includes 9 online modules designed to provide 'how-to' knowledge for researchers and biobankers and 'what is' knowledge for stakeholders (e.g. public, ethics board members). The CTRNet team is currently updating the Essentials course to align it to the ISBER Best Practices 5th Edition. This presentation will share details about the 9 online modules, how they can be accessed and when the update will be available for ISBER members and non-members.

Presented by:

• Jodi LeBlanc, BC Cancer, Canada
• Kate Lawrence, BC Cancer, Canada

 

Part 2 - INFORMATION MANAGEMENT IN BIOBANKING: The Nuts and Bolts of Implementing the ISBER Best Practices, 5th Edition IM section

Data associated with specimens is of utmost importance for effective scientific research and reproducibility. Extensive and accurate data associated with specimens is a fundamental asset to each repository. In addition, today's repositories are growing more dependent on data, and in tandem, on supporting data systems. These are key to a variety of functions including general operations, specimen management, communications, stakeholder relations, image or specimen analysis, shipping and logistics, automation, among many others.

Not only are specimen data collected or acquired, but other data are generated by a repository. Data not associated with specimens are often an untapped resource of use to the repository to optimize operations, as well as to other stakeholders, and can be termed repository operation data. Such data are extremely wide ranging and can include agreements with stakeholders, key performance metrics, and specimen location data, among many others.

Data that are specifically generated and used in managing operations can have various levels of sensitivity or confidentiality concerns. Therefore, it is critical to understand what data are collected, acquired, and/or generated during the different phases of the repository, both intended and unintended, and how to sufficiently protect and leverage these resources.

This workshop will support the understanding of the components of information management in biobanks and provide a forum to discuss examples of implementations, potential challenges, and interaction amongst participants about their data management strategies.

Presented by:

• Gregory Grossman, CSO, Advancing Sight Network, USA
• Chris Battison, REDCap Administrator / Research Data Analyst, Research Operations, The Center for Health Research Information Systems, Women’s College Hospital, Canada
• Marianne Henderson, Sr. Advisor for Division Resources and Biobanking, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, USA
• and additional members of the IM section for the BP 5th edition

Moderated by the biobanking 101/201 Task Force - Debra Garcia, Dee McGarvey, and Marianne Henderson

 

Learning Objectives

1) The integral role that information management plays in a biobank

2) How and why information management within and outside of the biobank should be interoperable

3) The major changes to Information Management section of the Best Practices 5th Edition

4) Example pathways to implementation of the BP recommendations for information management

 

To purchase the below workshop recordings, CLICK HERE.

Price: $45 USD Members / $120 USD Non-Members (per workshop)

Duration: 4 hours
This workshop features the following presentations presented by:

• Scott Jewell, Van Andel Research Institute, USA
• Galen Hostetter, Van Andel Research Institute, USA
• Dan Rohrer, Van Andel Research Institute, USA
• Melissa DeHollander, Van Andel Research Institute, USA
• Jingjing Wu, China Genebank (CNGB), China

Moderated by:

• Marianne Henderson, National Cancer Institute, USA
• Debra Garcia, Independent Consultant, USA
• Dee McGarvey, University of Pennsylvania, USA

 

SESSION 1: QUALITY IN BIOBANKING

Quality is essential in biobanking. The integrity and reliability of the samples stored is crucial for ensuring that research results are accurate and reproducible.

This year's 4-hour workshop will focus on quality as a key concept with components on human and enviro-bio biobanking. Due to the demand for the subject matter, the same material will be presented on April 19th and 20th/21st. This will allow our global audience the opportunity to participate in the workshop at a time that is most convenient for them. The presenters will touch on technologies and practices from collection/processing to distribution of samples and data, while including quality across the continuum.

Experts from the Van Andel Institute, Michigan, USA and China Genebank (CNGB), Shenzhen, China will introduce the basic concepts of quality across the biobanking continuum in human, animal and enviro-bio specimens and their data. The participants will have the opportunity to join in interactive activities to support their learning.

SESSION 2: THE BIOBANK ASSESSMENT TOOL (BAT) –YOUR PERSONAL GUIDE ALONG THE ROAD FOR HIGHER QUALITY

Presented by Karolin Bergenstrahle, Uppsala Biobank, Sweden

Is your biobank stuck in the work for quality and not know where to start? The ISBER Biobank Assessment Tool can support and direct your staff to the areas within your biobank that need extra attention to achieve adherence to the ISBER Best Practices (BPs). This presentation will answer questions of the scope of the tool, its target audience, and how it may be used routinely in any biobank organization to achieve a higher quality workflow and operations, per the ISBER BPs.